MycoMeditations Launches “The Bridge” to Connect Psychedelic Therapy with Traditional Mental Health Care

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire MycoMeditations Launches "The Bridge" to Connect Psychedelic Therapy with Traditional Mental Health CareAuthor of the article:THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountNew program enables clients’ existing therapists to collaborate directly with psychedelic treatment teams before and after retreats.TREASURE BEACH, Jamaica — Psychedelic therapy has a continuity-of-care problem. People often pursue treatment outside their existing mental health care, leaving their therapists disconnected from potentially significant therapeutic experiences.MycoMeditations is working to change that with the Bridge, a new program designed to connect clients’ existing mental health practitioners with the clinical team delivering their psilocybin-assisted therapy in Jamaica.This advertisement has not loaded yet, but your article continues below.“The person who knows a guest’s mental health history best is often the therapist they’ve been working with for years,” said Justin Townsend, Co-Founder and CEO of MycoMeditations. “The Bridge brings that relationship into the process, helping us build on the work already done and supporting continued progress once guests return home.”Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againAt the heart of The Bridge is a framework MycoMeditations calls bidirectional case transfer (BCT). With the client’s consent, their existing practitioner can share relevant treatment history and therapeutic insights with the retreat team before arrival. Following the retreat, MycoMeditations provides a clinical summary to support ongoing care.The result is a more connected therapeutic journey, rather than two separate treatment experiences.“As a therapist myself, I understand how valuable this information can be in supporting the therapeutic work that continues long after the retreat ends,” said Sadie Watts, Lead Therapist and Guest Intake Manager at MycoMeditations. “Ultimately, this wraparound service is designed to help guests better carry the insights and lessons from psychedelic therapy into their everyday lives, with ongoing support from the professionals who know and care for them.”MycoMeditations believes the Bridge represents one of the first formalized programs of its kind offered by a psychedelic retreat provider, and hopes its approach will encourage wider adoption of collaborative care across the industry.The Bridge is available at no additional cost to guests and participating practitioners, including psychologists, psychiatrists, psychotherapists, counselors, and coaches.Founded in 2014, MycoMeditations provides legal psilocybin-assisted therapy retreats in Jamaica. Its programs combine three psilocybin sessions with approximately 20 hours of therapeutic work, supported by licensed mental health professionals. More than 2,500 guests have participated in over 7,500 psilocybin sessions, with guest mental health outcomes tracked since 2021.View source version on businesswire.com: This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.